Who We Are?

He has over 30 years of experience in both Big Pharma (GSK and affiliates) and CROs (Aptuit and Evotec), holding increasingly responsible roles in research, strategic partnership development, and innovative business model implementation. At GSK, he played a key role in redefining lead optimization strategies to reduce clinical phase attrition. At Aptuit, he was instrumental in redefining and implementing an innovative business model capable of attracting integrated projects and long-term partnerships (Partnership Research Organization; PRO). He is also the author or co-author of over 25 scientific articles and is a regular speaker at international conferences and meetings.